33
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
Public Timelines
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
Créer
Close
Create a timeline
Public timelines
Library
FAQ
Éditer
Télécharger
Export
Créer une copie
Premium
Intégrer dans le site Web
Share
112017
Category:
Autre
mise à jour avec succès:
15 nov. 2017
new approvals in solid tumors
0
0
425
Auteurs
Created by
Paweł Potocki
Attachments
Comments
Les événements
Imatynib
Gefitynib
Erlotynib
Sorafenib
Sunitynib Dasatynib
Lapatynib Nilotynib
Pazopanib
wemurafenib kryzotynib ruksolitynib
aflibercept aksytynib enzalutamid ewerolimus kabozantynib pertuzumab regorafenib
afatatynib dabrafenib denosumab ibrutynib trametynib trastuzumab-emtanzyna rad-223
alektynib lenwatynib kobimetynib osimertynib palbocyklib sonidegib
ceritinib niwolumab olaparyb pembrolizumab ramucyrumab
atezolizumab rukaparyb olaratumab
abemacyklib awelumab brygantynib niraparyb neratynib rybocyklib
About & Feedback
Un accord
Confidentialité
Bibliothèque
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments